Authors:
GANELLIN CR
ROSE C
VARGAS F
FACCHINETTI P
BOURGEAT P
BAMBAL R
BISHOP PB
CHAN SMT
MOORE ANJ
SCHWARTZ JC
Citation: Cr. Ganellin et al., RATIONAL DESIGN OF BUTABINDIDE, THE FIRST INHIBITOR OF THE CHOLECYSTOKININ (CCK-8) INACTIVATING PEPTIDASE, British Journal of Pharmacology, 122, 1997, pp. 189-189
Authors:
SCARABIN PY
VISSAC AM
KIRZIN JM
BOURGEAT P
AMIRAL J
AGHER R
GUIZE L
Citation: Py. Scarabin et al., POPULATION CORRELATES OF COAGULATION-FACTOR-VII - IMPORTANCE OF AGE, SEX, AND MENOPAUSAL STATUS AS DETERMINANTS OF ACTIVATED FACTOR-VII, Arteriosclerosis, thrombosis, and vascular biology, 16(9), 1996, pp. 1170-1176
Citation: C. Rose et al., A RADIOIMMUNOASSAY FOR THE TRIPEPTIDE GLY-TRP-MET, A MAJOR METABOLITEOF ENDOGENOUS CHOLECYSTOKININ IN BRAIN, Neuropeptides, 30(3), 1996, pp. 231-235
Authors:
VISSAC AM
AMIRAL J
SCARABIN PY
LAROSA E
BOURGEAT P
KIRZIN JM
GUIZE L
Citation: Am. Vissac et al., CARDIOVASCULAR RISK-FACTORS AND D-DIMER CONCENTRATIONS IN A HEALTHY POPULATION AND A HYPERLIPEMIC GROUP, Thrombosis and haemostasis, 73(6), 1995, pp. 949-949
Authors:
BOURGEAT P
JASMIN P
MIGAUDFRESSART M
MARTINOLI JL
Citation: P. Bourgeat et al., DIRECT MEASUREMENT OF ACTIVATED F VII IN PLASMA - DEVELOPMENT OF AN ORIGINAL ASSAY, Thrombosis and haemostasis, 73(6), 1995, pp. 1204-1204
Authors:
SCARABIN PY
VISSAC AM
LAROSA E
BOURGEAT P
AMIRAL J
AGHER R
GUIZE L
Citation: Py. Scarabin et al., DETERMINANTS OF FACTOR-VII ACTIVITY AND ACTIVATION IN A HEALTHY POPULATION, Thrombosis and haemostasis, 73(6), 1995, pp. 1380-1380
Authors:
PLUBUREAU G
VISSAC AM
LAROSA E
BOURGEAT P
AMIRAL I
AGHER R
GUIZE L
SCARABIN PY
Citation: G. Plubureau et al., ASSOCIATION BETWEEN LOW-DOSE COMBINATION ORAL-CONTRACEPTIVES AND HEMOSTATIC VARIABLES - IMPORTANCE OF PROGESTOGENS, Thrombosis and haemostasis, 73(6), 1995, pp. 1385-1385